Huita Wu

1.2k total citations
15 papers, 273 citations indexed

About

Huita Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huita Wu has authored 15 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huita Wu's work include Ubiquitin and proteasome pathways (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Epigenetics and DNA Methylation (2 papers). Huita Wu is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Epigenetics and DNA Methylation (2 papers). Huita Wu collaborates with scholars based in China and United States. Huita Wu's co-authors include Zhenyu Yin, Chengrong Xie, Yuyan Lu, Qinliang Fang, Jing Lü, Fuqiang Wang, Jie Lv, Ping Zhan, Yu Xiong and Sheng Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Letters and Cell Death and Disease.

In The Last Decade

Huita Wu

14 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huita Wu China	7	189	93	79	72	37	15	273
Gaofeng Li China	9	224 1.2×	151 1.6×	57 0.7×	64 0.9×	30 0.8×	27	326
Fangfang Bu China	8	173 0.9×	90 1.0×	32 0.4×	107 1.5×	53 1.4×	9	285
Jianjun Xiao China	9	89 0.5×	75 0.8×	72 0.9×	115 1.6×	24 0.6×	16	222
Mika Chiba Japan	7	139 0.7×	75 0.8×	95 1.2×	120 1.7×	15 0.4×	8	241
Weiyu Dai China	9	207 1.1×	100 1.1×	57 0.7×	71 1.0×	23 0.6×	16	278
Mara Persano Italy	6	126 0.7×	84 0.9×	57 0.7×	159 2.2×	36 1.0×	31	274
Mengxi Xiu China	9	175 0.9×	112 1.2×	49 0.6×	58 0.8×	21 0.6×	14	277
Mengxian Tu China	6	116 0.6×	84 0.9×	40 0.5×	46 0.6×	45 1.2×	8	225
Simona Frezzini Italy	6	113 0.6×	89 1.0×	42 0.5×	93 1.3×	65 1.8×	8	231

Countries citing papers authored by Huita Wu

Since Specialization

Citations

This map shows the geographic impact of Huita Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huita Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huita Wu more than expected).

Fields of papers citing papers by Huita Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huita Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huita Wu. The network helps show where Huita Wu may publish in the future.

Co-authorship network of co-authors of Huita Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Huita Wu. A scholar is included among the top collaborators of Huita Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huita Wu. Huita Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lü, Jing, Huita Wu, Ping Zhan, et al.. (2025). PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1. Cell Death and Disease. 16(1). 141–141. 2 indexed citations

Wang, Hongliang, Sai Li, Chunchun Ma, et al.. (2025). Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme. Cell & Bioscience. 15(1). 60–60. 2 indexed citations

Wang, Jinan, et al.. (2024). Spectral CT for preoperative diagnosis of N2 station lymph node metastasis in solid T1 non-small cell lung cancer. European Journal of Radiology. 177. 111553–111553.

Yang, Zike, Huita Wu, Qing Lin, Xin Wang, & Shijun Kang. (2022). Lymphopenic condition enhanced the antitumor immunity of PD-1-knockout T cells mediated by CRISPR/Cas9 system in malignant melanoma. Immunology Letters. 250. 15–22. 5 indexed citations

Wu, Huita, et al.. (2022). Intravoxel incoherent motion diffusion-weighted imaging for early assessment of combined anti-angiogenic/chemotherapy for colorectal cancer liver metastases. Quantitative Imaging in Medicine and Surgery. 12(9). 4587–4600. 5 indexed citations

Wu, Huita, Yu Du, Xiao Li, et al.. (2021). Development and External Validation of a Nomogram for Predicting Overall Survival in Stomach Cancer: A Population-Based Study. Journal of Healthcare Engineering. 2021. 1–13. 2 indexed citations

He, Zhiyong, Jinghui Lin, Jing Zhang, et al.. (2021). The combination of EGFR-TKIs and anlotinib as a first-line therapy for EGFR-mutant advanced non-small cell lung cancer: A multicenter, single-arm, phase II clinical trial.. Journal of Clinical Oncology. 39(15_suppl). 9030–9030. 1 indexed citations

Xiong, Yu, Jing Lü, Qinliang Fang, et al.. (2019). UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells. Bioscience Reports. 39(4). 58 indexed citations

Lv, Jie, Sheng Zhang, Huita Wu, et al.. (2019). Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2. Cancer Letters. 469. 22–34. 83 indexed citations

10.

Wu, Huita, Fei Wang, Jie Lv, et al.. (2019). <p>The oncoprotein HBXIP facilitates metastasis of hepatocellular carcinoma cells by activation of MMP15 expression</p>. Cancer Management and Research. Volume 11. 4529–4540. 20 indexed citations

11.

Wang, Fei, Huita Wu, Sheng Zhang, et al.. (2019). <p>LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma</p>. Cancer Management and Research. Volume 11. 2485–2497. 18 indexed citations

12.

Wu, Huita, Chengrong Xie, Jie Lv, et al.. (2018). The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma. Laboratory Investigation. 98(8). 1014–1024. 22 indexed citations

13.

Lu, Yuyan, Jie Lv, Huita Wu, et al.. (2018). The long noncoding RNA lncPARP1 contributes to progression of hepatocellular carcinoma through up-regulation of PARP1. Bioscience Reports. 38(3). 19 indexed citations

14.

Wu, Huita, Jie Deng, Shiying Yu, Xin Wang, & Chen Yuan. (2010). The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms. Journal of Huazhong University of Science and Technology [Medical Sciences]. 30(1). 108–112. 6 indexed citations

15.

Wang, Xin, et al.. (2010). VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer. Journal of Surgical Oncology. 102(4). 325–330. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact